MYPT3 Antibodies

Santa Cruz Biotechnology offers a broad range of MYPT3 monoclonal antibodies for investigating MYPT3 in cellular processes. MYPT3 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MYPT3, or myosin phosphatase target subunit 3, plays a critical role in regulating smooth muscle contraction and cell motility by modulating myosin light chain phosphorylation. Its function is essential in various physiological processes, including vascular tone regulation and muscle contraction. Dysregulation of MYPT3 has been implicated in several pathological conditions, making it a significant target for research. MYPT3 monoclonal antibodies enable precise detection and analysis of protein expression patterns across different tissue types. Researchers can utilize MYPT3 monoclonal antibodies to explore protein-protein interactions and cellular localization patterns. Advanced visualization techniques with MYPT3 monoclonal antibodies allow for detailed examination of protein distribution in both normal and diseased states. Santa Cruz Biotechnology's MYPT3 monoclonal antibodies support the scientific community in advancing our understanding of cellular regulation and disease mechanisms.